Richard S. Shames, Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 7,058 shares at $20.50 ($145K) on 2017-12-22, disclosed to the SEC on 2017-12-27.
Open-market sale of $145k PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.50 | 3,529 | $72K | 50.0% |
| 2 | $20.50 | 3,529 | $72K | 50.0% |
| Total | $20.50 avg | 7,058 | $145K | 100% |
| Filing → |
| PTGX | SELL | 2017-10-10 | $38K | — | Filing → |
| PTGX | SELL | 2017-09-12 | $106K | — | Filing → |
| PTGX | SELL | 2017-08-30 | $26K | — | Filing → |